Trial design for metastatic castration-resistant prostate cancer - Reply Journal Article

  

Authors:	Scher, H. I.; Halabi, S.; Tannock, I. F.; Morris, M.; Sternberg, C. N.; Carducci, M. A.; Eisenberger, M. A.; Higano, C.; Bubley, G. J.; Dreicer, R.; Petrylak, D. P.; Kantoff, P.; Basch, E.; Kelly, W. K.; Figg, W. D.; Small, E. J.; Beer, T. M.; Wilding, G.; Martin, A.; Hussain, M.
Article Title:	Trial design for metastatic castration-resistant prostate cancer - Reply
Keywords:	treatment outcome; survival rate; anamnesis; drug withdrawal; letter; prostate specific antigen; steroid; clinical protocol; practice guideline; prostate cancer; therapy delay; aminoglutethimide; antiandrogen; ketoconazole; half life time; megestrol acetate
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	21
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-01-01
Start Page:	3648
End Page:	3649
Language:	English
DOI:	10.1200/jco.2008.17.2494
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-51349132478&partnerID=40&md5=34619c3468e39bc03f2f6885312bf193
Notes:	--- - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15296